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Pyogenic hepatic abscess: clues for diagnosis in the emergency room
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The objective of this paper is to describe the clinical and diagnostic characteristics of patients with
pyogenic hepatic abscesses evaluated in the emergency room, and to know whether it is feasible to make an
early diagnosis based on any of these characteristics. The setting was an urban, tertiary-care teaching
hospital. This was a retrospective study of 63 adult patients admitted to our institution because of
pyogenic liver abscesses from January 1991 to December 1998.
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INTRODUCTION
Pyogenic hepatic abscess (PHA) represents an infrequent and
sometimes life-threatening entity [1]. Its recognition has clearly
improved in the last decade through the development of more
sensitive and specific imaging techniques, such as ultrasono-
graphy (US) and computed tomography (CT), with their
relevant therapeutic implications [2,3]. Standard treatment
protocols usually recommend a combination of drainage and
antimicrobial therapy, although no specific antibiotic schemes
have been defined due to the lack of large, prospective studies [4].
Diagnosing PHA in an initial stage remains a difficult task
today, frequently due to the paucity of the presenting symptoms
or the radiological features. However, several studies have
confirmed that an early diagnosis is associated with improved
survival [5–7].
This study will describe the clinical and diagnostic charac-
teristics of patients with PHA evaluated at a first-step hospital
level, the emergency room (ER).
PATIENTS AND METHODS
The medical records of all adult patients admitted between
January 1991 and December 1998 at the Marque´s de
Valdecilla University Hospital, and discharged with a diagnosis
of PHA, were reviewed. This is an 1100-bed tertiary-care center
that serves as the reference hospital for a population of 500 000,
and as the first-level hospital for an area including about 350 000
inhabitants in Northern Spain. Therefore, this population
can be regarded as an unselected sample of this entity in our area.
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Data were obtained by a retrospective review of clinical charts
of patients with PHA, selected through the computerised data-
base of the Admissions andClinical Documentation Department.
PHA was defined on the evidence of one or more liver
collections without radiological characteristics of malignancy, in
US or CT studies, along with the identification of pus or
bacteria, either microscopically or by culture [5].
For the purposes of the study, patients were divided into two
different groups. Those patients in whom a diagnosis of PHA
was reached in the ER, constituted group A. Group B con-
tained those patients in whom PHA was not detected in the ER
evaluation.
The median follow-up of patients was 12 months. Data on
recurrence and mortality were also collected. PHA-related
mortality included both mortality resulting directly from the
abscess and mortality from a treatment complication.
Continuous variables are expressed as mean  standard
deviation and are analysed using the Mann–Whitney test.
Pearson’s w2 test or Fisher exact test (when expected frequencies
were <5) were used to compare qualitative variables between




There were 63 patients with PHA during the study period. Of
these, 11 (17.5%) were correctly diagnosed in the ER (group
A), and 52 (82.5%) were admitted without a specific diagnosis
(group B). The mean age at admission was 59.8 16.5 years for
the whole sample. In group A, the mean age was 49.3
8.8 years, and in group B it was 61.9 15.3 years (P¼ 0.03).
There were 26 patients older than 65 years. Of these, diag-
nosis was only suspected in two cases (7.7%). In the group of
patients younger than 65 years (37 cases), PHA was suspected in
nine patients (24.3%).
The ratios of males to females were 1.2 : 1.0 in the group of
patients with PHA diagnosed at ER (group A), and 1.7 : 1.0 in
group B. The mean duration of symptoms before ER evaluation
was 8.8 8.2 days versus 12.6 14.5 in groups A and B
respectively.
Presenting symptoms and physical examination
The chief complaint in the ER was fever; seven cases (63.3%) in
group A, and 41 (78.8%) in group B. Fever was noticed by 22 of
26 patients older than 65 years. Abdominal pain was reported
more frequently by group B patients (24 cases versus four in
group A). Chills were noticed by five patients (45.5%) in group
A, and by 17 (32.7%) individuals in group B.
During the physical examination, jaundice was noted in five
patients of group A (45.5%), and only in 11 (21.2%) of group B.
In group B, hepatomegaly was detected more frequently than in
group A (Table 1). No statistically significant difference was
detected between the groups, although there was a trend
towards a greater presence of jaundice at admission in group
A patients (P¼ 0.09).
Predisposing conditions
Table 2 shows the predisposing conditions found in both groups
of patients. A past medical history of orthotopic liver trans-
plantation (P¼ 0.001) or biliary tract disease (P¼ 0.05) favored
a diagnosis of PHA in the ER. Globally, antecedent hepato-
biliary disorders (including orthotopic liver transplantation),
lead to a higher index of suspicion in the ER clinicians
(P¼ 0.004). Some form of immunosuppression was detected
in five out of 11 patients in group A, and in seven out of 45 in
group B (P¼ 0.02). Other predisposing conditions found in our
patients were as follows: alcoholism (two cases); recent (in the
previous week) abdominal surgery (two patients); chronic
brucellosis (one case); steroidal and immunosuppressive therapy
(one patient with rheumatoid arthritis and one case of systemic
vasculitis, respectively).
Radiological findings
A radiograph of the chest showed a greater number of pati-
ents with laminar atelectasis (P¼ 0.09), and pleural effusion







Fever 7 (63.3) 41 (78.8)
Abdominal pain 4 (36.4) 24 (46.2)
Chills 5 (45.5) 17 (32.7)
Asthenia 4 (36.4) 14 (26.9)
Anorexia 2 (18.2) 12 (23.1)
Weight loss 2 (18.2) 11 (21.2)
Ascites ^ 2 (3.8)
Jaundice 5 (45.5) 11 (21.2)
Hepatomegaly 2 (18.2) 11 (21.2)






n (%) P value
HIV infection ^ 5 (9.6) NS
Liver transplant recipient 5 (45.5) 2 (3.8) 0.001
Biliary tract disease 5 (45.5) 9 (17.3) 0.05
Concomitant neoplasma ^ 5 (9.6) NS
Diabetes mellitus ^ 9 (17.3) NS
aCholangiocarcinoma (three cases), colorectal neoplasms (two patients).
HIV, human immunodeficiency virus; NS, not significant.
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(P¼ 0.1) in group A than in group B (see Table 3). Globally,
radiological alterations (atelectasis, pleural effusion, or elevated
right hemidiaphragm) on plain chest films were more frequent
in the patients correctly diagnosed in the ER (P¼ 0.05).
Abdominal US was performed in all the cases diagnosed in
the ER (Figure 1). PHA were multiple in five cases (45.5%) of
group A (Figure 2), and in 25 (48.1%) of group B patients. In
group A, there was one case (9.1%) of concomitant splenic
abscesses, and six of these cases (11.5%) in group B. Ascites
was demonstrated in two patients in each group (18.2% versus
3.8%, P< 0.001) using US, but it was clinically detected only
in group B patients (both with a previous diagnosis of
cholangiocarcinoma).
Laboratory parameters
No difference was found in the hematological values or in the
liver function tests of both groups of patients. Only a trend
towards a greater increase of the erythrocyte sedimentation rate
was noted in the group A patients in comparison to group B (84
versus 60 mm/h; P ¼ 0.07).
Microbiological data
The causative micro-organisms did not differ between the
groups; enteric Gram-negative bacilli being the most frequently
isolated. Table 4 shows the main microbiological data of the
whole sample.
Outcome
The length of stay of group A patients was 45.0 50.4 days, and
34.3 22.1 days in the group B. There were two cases of
recurrent PHA in the group of patients diagnosed in the ER,
and seven in group B. Two out of 11 patients (18.2%) in group
A, and seven out of 52 (13.5%) patients in group B, died.
DISCUSSION
Based upon the lack of specificity of clinical symptoms and
signs, as well as laboratory parameters, diagnosing PHA remains
a difficult task for the clinician. This is particularly important in
the ER, since the time for a patient’s evaluation is often limited.
A diagnosis of suspicion of PHA was made in the ER in
nearly one-sixth of our patients. The patients correctly diag-
nosed at admission were younger than the patients undiagnosed.
Thus, in this study, age was an important clue when deciding to
request an US examination in patients suspectedof having a PHA.
PHA was traditionally considered as a subacute entity, with a
median of symptom duration before admission of over 2 weeks







Atelectasis 3 (27.3) 4 (7.7)
Pleural effusion 6 (54.5) 15 (28.8)
Elevated right hemidiaphragm 1 (9.1) 5 (9.6)
Figure 1 Abdominal ultrasonography showing a large and heterogeneous
hepatic collection.
Figure 2 Contrast enhanced CT-scan showing two multiloculated hepatic
abscesses affecting both lobes.





Gramnegative 22 (34.9) Escherichia coli (8)
Klebsiella pneumoniae (7)
Grampositive 11 (17.5) Enteroccoccus faecalis (4)
Viridans streptococci (3)
Anaerobes 5 (7.9) Prevotella spp. (2)
Bacteroides fragilis (1)
None 25 (39.7)
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[8]. However, in our series the median duration of symptoms
prior to ER evaluation was 9 days in the group A patients. It has
been suggested that the underlying condition may influence the
presentation in an individual patient [9]. In our study this may
be explained, at least in part, by the greater presence of liver
transplantation recipients in group A. The presence of fever or
abdominal pain in these patients, probably leads to a prompt
medical consultation.
A past medical history of orthotopic liver transplantation or
biliary tract disorders, also led to a higher index of suspicion by
the ER clinicians. In fact, 10 out of 11 patients correctly
diagnosed had one of these conditions.
The combination of fever and right upper quadrant pain,
classically associated with PHA, was only found in 19 (30.1%)
patients in our series, reflecting the non-specific nature of
clinical presentation in many cases, and the difficulty of an
early diagnosis [10].
Physical examination data were not helpful for the physicians
in the ER in most of the cases. In this regard, a classical sign such
as jaundice was present in only one-quarter of our cases.
However, it was the only feature that led to a more accurate
diagnosis (45.5% of group A vesrus 21.2% of group B), although
its importance did not reach statistical significance in our study,
probably due to the size of the sample.
Chest radiographs showed laminar atelectasis in nearly one-
third of the group A patients, associated with right pleural
effusion in half of them. These findings are consistent with those
previously published in the literature [10]. In the setting of a
patient with a clinical suspicion of PHA, these chest X-ray abnor-
malities probably reinforced the diagnosis, as our study suggest.
At admission, the presence of multiple abscesses in the US
study did not correlate with a more accurate diagnosis, although
they were more frequently detected in immunosuppressed
patients, as the literature states [8,10]. According to the chest
X-ray findings, there were no differences in the accuracy of the
diagnosis of suspicion between the groups, although radio-
graphic abnormalities were more frequent in the group with
multiple PHA, particularly laminar atelectasis and pleural effu-
sion. The higher rate of immunosuppression added to the fact
that hematogenous spread was predominant in this group, may
explain the remarkable incidence of splenic abscesses in these
patients.
Laboratory parameters were not helpful to the ER clinicians
to increase their index of suspicion for PHA. Retrospectively,
causative micro-organisms were not different between both
groups, and no severity patterns could be related to the etio-
logical agent at admission.
There was no association between a correct diagnosis in the
ER and the length of stay, nor with the rates of recurrence or
mortality. The most important determinant of mortality in our
patients, appeared to be the presence of severe underlying
diseases, as Seeto and Rockey have already pointed out [5].
In this regard, we found a higher rate of immunosuppressed
patients in group A, which could certainly affect the length of
stay and the prognosis in our series.
The two main limitations of our study are the size of the
sample and its retrospective nature. However, in the case of
PHA, large and prospective studies are lacking and, to our
knowledge, none of them are focused on the accuracy of
diagnosis in the ER.
In summary, diagnosing PHA in the ER remains a challen-
ging problem for the clinician owing to the paucity of the
symptoms and signs. In this study, we have found a subgroup of
patients with a high index of suspicion for PHA at admission;
younger, immunosuppressed, and with a past medical history of
biliary tree disorders. Conversely, an early diagnosis was a
difficult task in elderly patients.
Therefore, the first evaluation of an occult liver abscess may
be improved by a history directed to identification predisposing
conditions, mainly immunosuppression and hepatobiliary dis-
orders. The presence of right atelectasis or pleural effusion in
the chest radiograph could reinforce this suspicion in most of
the patients, even in the absence of the classical clinical features.
In these cases, an abdominal US or CT study would be strongly
advised.
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